A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis. uri icon

authors

  • West, Tim
  • Bateman, Randall J
  • David M. Holtzman, MD
  • Verghese, Philip B
  • Fogelman, Ilana
  • Braunstein, Joel B
  • Yarasheski, Kevin E
  • Kirmess, Kristopher M
  • Meyer, Matthew R
  • Holubasch, Mary S
  • Knapik, Stephanie S
  • Hu, Yan
  • Contois, John H
  • Jackson, Erin N
  • Harpstrite, Scott E

publication date

  • January 1, 2021